Literature DB >> 21931056

High-mobility group box 1 protein (HMGB1) as a novel diagnostic tool for toxic epidermal necrolysis and Stevens-Johnson syndrome.

Saeko Nakajima, Hideaki Watanabe, Mikiko Tohyama, Kazunari Sugita, Masafumi Iijima, Koji Hashimoto, Yoshiki Tokura, Youichi Nishimura, Hiromi Doi, Miki Tanioka, Yoshiki Miyachi, Kenji Kabashima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21931056     DOI： 10.1001/archdermatol.2011.239

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  10 in total

Review 1.  Biomarkers of adverse drug reactions.

Authors:  Daniel F Carr; Munir Pirmohamed
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-26

Review 2.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

3.  Recent progress of elucidating the mechanisms of drug hypersensitivity.

Authors:  Hideo Hashizume
Journal:  Asia Pac Allergy       Date:  2012-07-25

Review 4.  Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances.

Authors:  Teresa Bellón
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.228

5.  Activation of the HMGB1‑TLR4‑NF‑κB pathway may occur in patients with atopic eczema.

Authors:  Yong Wang; Hui Weng; Jian Fei Song; Yun Hua Deng; Shuang Li; Hong Bo Liu
Journal:  Mol Med Rep       Date:  2017-07-06       Impact factor: 2.952

6.  Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  D F Carr; C-W Wang; T Bellón; L Ressel; G Nwikue; V Shrivastava; W Bergfeld; A L Jorgensen; W-H Chung; M Pirmohamed
Journal:  Br J Dermatol       Date:  2019-03-26       Impact factor: 9.302

Review 7.  Novel insights into the role of immune cells in skin and inducible skin-associated lymphoid tissue (iSALT).

Authors:  Sachiko Ono; Kenji Kabashima
Journal:  Allergo J Int       Date:  2015-09-28

Review 8.  Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.

Authors:  Hideaki Watanabe
Journal:  J Immunol Res       Date:  2018-03-18       Impact factor: 4.818

9.  Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!

Authors:  Rajesh Kumar; Anupam Das; Sudip Das
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

Review 10.  Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).

Authors:  E C Kuijper; L E French; C P Tensen; M H Vermeer; J N Bouwes Bavinck
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.